Abstract
Background:
There are limited data on uninsured patients presenting with acute myocardial infarction-cardiogenic shock (AMI-CS). This study sought to compare the management and outcomes of AMI-CS between uninsured and privately insured individuals.
Methods:
Using the National Inpatient Sample (2000–2016), a retrospective cohort of adult (≥18 years) uninsured admissions (primary payer - ‘self-pay’ or ‘no charge’) were compared to privately insured individuals. Inter-hospital transfers were excluded. Outcomes of interest included in-hospital mortality, temporal trends in admissions, use of cardiac procedures, do-not-resuscitate (DNR) status, palliative care referrals, and resource utilization.
Results:
Of 402,182 AMI-CS admissions, 21,966 (5.4%) and 93,814 (23.3%) were uninsured and privately insured. Compared to private insured individuals, uninsured admissions were younger, male, from a lower socio-economic status, had lower comorbidity, higher rates of acute organ failure, ST-segment elevation AMI-CS (77.3% vs. 76.4%), and concomitant cardiac arrest (33.8% vs. 31.9%) (all p<0.001). Compared to 2000, in 2016, there were more uninsured (adjusted odds ratio [aOR] 1.15 [95% confidence interval {CI} 1.13–1.17]; p<0.001) and less privately insured admissions (aOR 0.85 [95% CI 0.83–0.87]; p<0.001). Uninsured individuals received less frequent coronary angiography (79.5% vs. 81.0%), percutaneous coronary intervention (60.8% vs. 62.2%), mechanical circulatory support (54% vs. 55.5%), and had higher palliative care (3.8% vs. 3.2%) and DNR status use (4.4% vs. 3.2%) (all p<0.001). Uninsured admissions had higher in-hospital mortality (aOR 1.62 [95% CI 1.55–1.68; p<0.001) and resource utilization.
Conclusions:
Uninsured individuals have higher in-hospital mortality and lower use of guideline-directed therapies in AMI-CS compared to privately insured individuals.
Keywords: Acute myocardial infarction, cardiogenic shock, insurance, health care disparities, outcomes research
INTRODUCTION
Insurance status has shown to be related to clinical outcomes in both the cardiac and non-cardiac literature.1, 2 As of 2017, the uninsured population in the United States is approximately 9%, compared to 67% of individuals who obtain private insurance.3 In patients with acute myocardial infarction (AMI), large retrospective studies have previously demonstrated the lack of health insurance and Medicaid status to be associated with worse mortality and higher readmission rates compared to patients with private insurance.2, 4, 5 Age impacts primary payer status, with a larger proportion of non-ST-segment AMI patients bearing Medicare insurance, whereas patients with ST-segment-elevation AMI have other forms of insurance.6, 7 Prior data from the AMI literature has noted insurance-specific differences between those with Medicare and Medicaid and other carriers. Specifically, Medicare patients are older, and have higher comorbidities, and therefore may receive less frequent guideline-directed therapies due to risk of complications.6, 7 In contrast, though Medicaid patients are younger, hospitals are reimbursed lesser for Medicaid patients, raising concerns that they might systematically receive less aggressive therapy.1, 2
Cardiogenic shock (CS) constitutes the sickest spectrum of AMI, and continues to be associated with nearly 30–40% mortality and morbidity in the contemporary era.8–18 Patients with AMI-CS frequently require intensive care unit hospitalizations, use of cardiac and non-cardiac procedures such as coronary angiography, percutaneous coronary intervention (PCI), temporary mechanical circulatory support (MCS), mechanical ventilation and hemodialysis.8–18 As noted by our group previously, this high-acuity and resource heavy population have an average charge of $80,000–180,000.9 It conceivable that given the high costs associated with this disease process, that insurance status may play a role in the management and outcomes of these patients. There are limited data that suggests that clinical outcomes in AMI-CS populations will also vary based on insurance status.19, 20 However, these prior studies have largely focused on patients bearing certain types of insurance (Medicare, Medicaid, private, etc.) and therefore there is a paucity of contemporary data on uninsured patients. Typically, privately insured individuals receive the most aggressive care when presenting with an AMI, and therefore it is important to contrast the outcomes of uninsured group against this insurance group.1, 2, 6, 7
Considering this background, using a nationally representative population, we sought to assess the management and outcomes of uninsured individuals compared to privately insured individuals presenting with AMI-CS. In addition, we evaluated the temporal trends in admissions, use of cardiac and non-cardiac procedures, and clinical outcomes of these populations.
MATERIAL AND METHODS
Study Population, Variables and Outcomes
The National (Nationwide) Inpatient Sample (NIS) is the largest all-payer database of hospital inpatient stays in the United States. NIS contains discharge data from a 20% stratified sample of community hospitals and is a part of the Healthcare Quality and Utilization Project (HCUP), sponsored by the Agency for Healthcare Research and Quality.21 Information regarding each discharge includes patient demographics, primary payer, hospital characteristics, principal diagnosis, up to 24 secondary diagnoses, and procedural diagnoses. The HCUP-NIS does not capture individual patients but captures all information for a given admission. Institutional Review Board approval was not sought due to the publicly available nature of this de-identified database. These data are available to other authors via the HCUP-NIS database with the Agency for Healthcare Research and Quality.21
Using the HCUP-NIS data from 2000–2016, a retrospective cohort study of adult admissions (≥18 years of age) with AMI in the primary diagnosis field (International Classification of Diseases 9.0 Clinical Modification [ICD-9CM] 410.x and ICD-10CM I21.x-22.x) and a secondary diagnosis of CS (ICD-9CM 785.51, ICD-10CM R57.0) were identified. The HCUP-NIS contains data on the expected primary payers as Medicare (includes fee-for-service and Medicare Advantage), Medicaid (includes fee-for-service and managed care), private insurance, self-pay, no charge, others, or missing. Consistent with prior literature, admissions in which the primary payer was designated as ‘self-pay’ or ‘no charge’ were considered uninsured and were compared to privately insured individuals.2, 4 Admissions with other primary payer categories, inter-hospital transfers and those without in-hospital mortality data were excluded. The Deyo’s modification of the Charlson Comorbidity Index was used to identify the burden of co-morbid diseases (Supplementary Table 1).22 Demographic characteristics, hospital characteristics, acute organ failure, mechanical circulatory support, cardiac procedures, and non-cardiac organ support use were identified for all admissions using previously used methodologies from our group.23–39
The primary outcome was the in-hospital mortality in uninsured AMI-CS admissions compared to private insured individuals. Secondary outcomes included temporal trends in admissions, use of coronary angiography, PCI, MCS, use of do-not-resuscitate (DNR) status, palliative care referrals, hospitalization costs, length of hospital stay and discharge disposition in uninsured and privately insured individuals with AMI-CS. A sensitivity analysis was performed for the cohorts without DNR status, palliative care referral and those not discharged against medical advice.
Statistical Analysis
As recommended by HCUP-NIS, survey procedures using discharge weights provided with HCUP-NIS database were used to generate national estimates.40, 41 Using the trend weights provided by the HCUP-NIS, samples from 2000–2011 were re-weighted to adjust for the 2012 HCUP-NIS re-design.40, 41 Chi-square/one-way analysis of variance and t-tests were used to compare 2/≥2 categorical and continuous variables, respectively. Multivariable logistic regression was used to analyze trends over time (referent year 2000). All analyses were conducted accounting for survey nature (SURVEYMEANS, SURVEYLOGISTIC, and SURVEYFREQ), clustering of admissions within a hospital (HOSP_NIS), weighting (DISCWT), and stratification (NIS_STRATUM) of the NIS. The inherent restrictions of the HCUP-NIS database related to research design, data interpretation, and data analysis were reviewed and addressed.40, 41 Pertinent considerations include not assessing individual hospital-level volumes (due to changes to sampling design detailed above), treating each entry as an ‘admission’ as opposed to individual patients, restricting the study details to inpatient factors since the HCUP-NIS does not include outpatient data, and limiting administrative codes to those previously validated and used for similar studies. Univariable analysis for trends and outcomes was performed and was represented as odds ratio (OR) with 95% confidence interval (CI). Multivariable logistic regression analysis incorporating age, sex, race, socio-economic stratum, hospital characteristics, comorbidities, acute organ failure, AMI-type, cardiac procedures, non-cardiac procedures, DNR status and palliative care referral was performed for assessing temporal trends of in-hospital mortality. Multiple sub-group analyses stratifying by age (≤75 years vs. >75 years), sex (male/female), race (white/non-white), type of AMI-CS (STEMI-CS/NSTEMI-CS) and presence of cardiac arrest (yes/no) were performed to confirm the findings of the primary analysis. For the multivariable modeling, regression analysis with purposeful selection of statistically (liberal threshold of p<0.20 in univariate analysis) and clinically relevant variables was conducted. Two-tailed p<0.05 was considered statistically significant. All statistical analyses were performed using SPSS v25.0 (IBM Corp, Armonk NY).
RESULTS
In the period from January 1, 2000, to December 31, 2016, there were over 10 million AMI admissions, of which 402,182 constituted AMI-CS admissions without inter-hospital transfer. Primary payer status was not listed for 643 (0.2%) admissions. Medicare, Medicaid, and Others constituted 250,349 (62.1%), 26,321 (6.5%), and 9,732 (2.4%) respectively and were excluded. Uninsured and privately insured individuals constituted 21,966 (5.4%) and 93,814 (23.3%) admissions and were studied further. Compared to private insured individuals, uninsured individuals were younger, more often male, of non-white race, from a lower socio-economic status, had lower comorbidity and were more frequently admitted to rural hospitals (Table 1). Uninsured individuals had higher rates of acute organ failure, ST-segment elevation AMI-CS (77.3% vs. 76.4%), cardiac arrest (33.8% vs. 31.9%), invasive mechanical ventilation (45.4% vs. 40.6%), but lower use of pulmonary artery catheters and non-invasive ventilation compared to privately insured individuals (all p<0.001) (Table 1). During the 17-year study period, there was a steady increase in unadjusted and adjusted rates of uninsured AMI-CS admissions and a steady decrease in privately insured individuals (Figure 1A and 1B).
Table 1.
Characteristics of uninsured and private insured AMI-CS admissions
| Characteristics | Uninsured (N=21,966) |
Private Insured (N=93,814) |
P | |
|---|---|---|---|---|
| Age (years) | 56.5±10.2 | 59.8±10.8 | <0.001 | |
| Age >75 years | 5.3% | 9.6% | <0.001 | |
| Female sex | 26.9 | 28.3 | <0.001 | |
| Weekend admission | 28.1 | 28.7 | 0.09 | |
| Race | White | 52.9 | 63.3 | <0.001 |
| Black | 8.7 | 5.6 | ||
| Others a | 38.4 | 31.1 | ||
| Quartile of median household income for zip code | 0–25 th | 31.2 | 17.9 | <0.001 |
| 26 th -50 th | 26.0 | 23.6 | ||
| 51 st -75 th | 24.7 | 27.3 | ||
| 75 th -100 th | 18.0 | 31.2 | ||
| Charlson Comorbidity Index | 0–3 | 61.0 | 51.2 | <0.001 |
| 4–6 | 34.2 | 40.6 | ||
| ≥ 7 | 4.8 | 8.3 | ||
| Hospital teaching status and location | Rural | 6.0 | 5.1 | <0.001 |
| Urban non-teaching | 41.5 | 43.1 | ||
| Urban teaching | 52.5 | 51.8 | ||
| Hospital bed-size | Small | 7.6 | 7.8 | 0.46 |
| Medium | 23.9 | 24.1 | ||
| Large | 68.6 | 68.2 | ||
| Hospital region | Northeast | 9.8 | 15.7 | <0.001 |
| Midwest | 17.6 | 23.8 | ||
| South | 54.5 | 38.1 | ||
| West | 18.2 | 22.4 | ||
| AMI type | ST-segment elevation | 77.3 | 76.4 | 0.004 |
| Non-ST-segment elevation | 22.7 | 23.6 | ||
| Acute organ failure | Respiratory | 46.7 | 44.7 | <0.001 |
| Renal | 30.7 | 29.7 | 0.003 | |
| Hepatic | 11.1 | 9.2 | <0.001 | |
| Hematologic | 10.4 | 11.1 | 0.002 | |
| Neurologic | 17.4 | 16.2 | <0.001 | |
| Out of hospital cardiac arrest | 33.8 | 31.9 | <0.001 | |
| Pulmonary artery catheterization | 5.9 | 7.6 | <0.001 | |
| Invasive mechanical ventilation | 45.4 | 40.6 | <0.001 | |
| Non-invasive ventilation | 2.3 | 2.6 | 0.004 | |
| Hemodialysis | 2.4 | 2.6 | 0.08 | |
Represented as percentage or mean ± standard deviation;
Hispanic, Asian, Native American, Others
Abbreviations: AMI: acute myocardial infarction; CS: cardiogenic shock
Figure 1. Temporal trends of uninsured and privately insured AMI-CS admissions.

A: 17-year unadjusted trends in uninsured and privately insured AMI-CS admissions; all p<0.001 for trend over time; B: Adjusted multivariate logistic regression for temporal trends in uninsured and privately insured AMI-CS admissions (2000 as referent year); adjusted for age, sex, race, comorbidity, socio-economic stratum, hospital characteristics, and comorbidities; p<0.001 for trend over time.
Abbreviations: AMI: acute myocardial infarction; CS: cardiogenic shock
Coronary angiography, PCI, and MCS were used less frequently in uninsured individuals during the study period (Table 2). Temporal trend analyses showed an increase in utilization of coronary angiography and PCI during the 17-year period; however uninsured individuals consistently received these procedures less frequently (Figures 2A and 2B). There has been an overall decrease in total MCS use during the study period that is primarily due to a decrease in intra-aortic balloon pump utilization (Figures 2C and 2D). There has been a steady increase in percutaneous left ventricular assist device and extracorporeal membrane oxygenation use, with lower rates in the uninsured population (Table 2 and Figures 2E and 2F). The uninsured population had higher use of DNR status (4.4% vs. 3.2%) and higher rates of palliative care referral (3.8% vs. 3.2%) compared to privately insured individuals.
Table 2.
Clinical outcomes of uninsured and private insured AMI-CS admissions
| Outcomes | Uninsured (N=21,966) |
Private Insured (N=93,814) |
P | |
|---|---|---|---|---|
| Coronary angiography | 79.5 | 81.0 | <0.001 | |
| Percutaneous coronary intervention | 60.8 | 62.2 | <0.001 | |
| Mechanical circulatory support | Total | 54.0 | 55.5 | <0.001 |
| Intra-aortic balloon pump | 51.7 | 53.1 | <0.001 | |
| Percutaneous LVAD | 2.7 | 2.6 | <0.001 | |
| ECMO | 0.7 | 1.0 | <0.001 | |
| Do-not-resuscitate status | 4.4 | 3.2 | <0.001 | |
| Palliative care referral | 3.8 | 3.2 | <0.001 | |
| In-hospital mortality | 34.7 | 25.8 | <0.001 | |
| Length of stay (days) | 8.9±10.7 | 9.3±9.9 | <0.001 | |
| Hospitalization costs (x1000 US Dollars) | 135±143 | 145±166 | <0.001 | |
| Disposition | Home | 68.3 | 55.9 | <0.001 |
| Transfer | 11.7 | 13.9 | ||
| Skilled nursing facility | 7.1 | 15.8 | ||
| Home with home health care | 11.1 | 14.2 | ||
| Against medical advice | 1.7 | 0.3 | ||
Represented as percentage or mean ± standard deviation
Abbreviations: AMI: acute myocardial infarction; CS: cardiogenic shock; ECMO: extracorporeal membrane oxygenation; LVAD: left ventricular assist device; US: United States
Figure 2. Temporal trends in cardiac procedures in uninsured and privately insured AMI-CS admissions.

Seventeen-year trends of coronary angiography (A), PCI (B), total MCS (C), IABP (D), pLVAD* (E) and ECMO (F) in uninsured and privately insured AMI-CS admissions; all p<0.001 for trend
*The administrative codes for pLVAD were introduced in 2004, and therefore temporal trends are presented from 2005 onwards
Abbreviations: AMI: acute myocardial infarction; CS: cardiogenic shock; ECMO: extracorporeal membrane oxygenation; IABP: intra-aortic balloon pump; MCS: mechanical circulatory support; PCI: percutaneous coronary intervention; pLVAD: percutaneous left ventricular assist device
The all-cause in-hospital mortality in uninsured individuals was higher than that in privately insured individuals (34.7% vs. 25.8%; OR 1.53 [95% CI 1.48–1.58]; p<0.001). There was a consistent decrease in in-hospital mortality across both categories during this 17-year study period (Figure 3). In a multivariable logistic regression for in-hospital mortality, the uninsured AMI-CS admissions had higher mortality compared to privately insured individuals (OR 1.62 [95% CI 1.55–1.68; p<0.001) (Supplementary Table 2). The uninsured group had shorter hospital stay, lower hospitalization costs, fewer discharges to skilled nursing facilities and higher rates of discharges against medical advice (Table 2).
Figure 3. Temporal trends of in-hospital mortality in uninsured and privately insured AMI-CS admissions.

A: Unadjusted in-hospital mortality in uninsured and privately insured AMI-CS admissions; p<0.001 for trend over time; B: Adjusted multivariate logistic regression for temporal trends of in-hospital mortality in uninsured and privately insured AMI-CS admissions (2000 as referent year); adjusted for age, sex, race, comorbidity, socio-economic stratum, hospital characteristics, comorbidities, AMI type, acute organ failure, cardiac arrest, coronary angiography, percutaneous coronary intervention, mechanical circulatory support, invasive mechanical ventilation, acute hemodialysis; p<0.001 for trend over time.
Abbreviations: AMI: acute myocardial infarction; CS: cardiogenic shock
In pre-specified sub-groups stratified by age, sex, race, type of AMI-CS and presence of cardiac arrest, uninsured AMI-CS admissions consistently had higher in-hospital mortality than privately insured individuals (Figure 4). In a sensitivity analysis excluding those without DNR status, palliative care referral and not discharged against medical advice, the uninsured cohort continued to have higher in-hospital mortality (30.8% vs. 22.8%; unadjusted OR 1.51 [95% CI 1.46–1.56]; adjusted OR 1.60 [95% CI 1.55–1.65]; p<0.001).
Figure 4. Adjusted odds ratio for in-hospital mortality in uninsured AMI-CS admissions as compared to privately insured individuals.

Adjusted odds ratios*(with 95% confidence interval) for in-hospital mortality in uninsured AMI-CS admissions compared to privately insured individuals
*Adjusted for age, sex, race, comorbidity, socio-economic stratum, hospital characteristics, comorbidities, AMI type, acute organ failure, cardiac arrest, coronary angiography, percutaneous coronary intervention, mechanical circulatory support, invasive mechanical ventilation, acute hemodialysis
Abbreviations: AMI: acute myocardial infarction; CS: cardiogenic shock; IHM: in-hospital mortality NSTEMI: non-ST-segment elevation myocardial infarction; STEMI: ST-segment elevation myocardial infarction
DISCUSSION
In the largest study looking at the effects of being uninsured on the clinical management and outcomes of AMI-CS, we identify significant health care disparities. Slightly over 5% of all AMI-CS admissions during this 17-year study period were in individuals who were uninsured and were typically younger, male, of non-white race, and from a lower socio-economic status. Despite higher acuity, these individuals received less frequent coronary angiography, PCI, pulmonary artery catheterization, and MCS. The uninsured population had higher use of DNR status and palliative care referrals, shorter hospital stays and fewer discharges to skilled nursing facilities. Compared to privately insured individuals, uninsured AMI-CS admissions consistently had higher in-hospital mortality despite being younger and with fewer comorbidities.
The findings of this study appear to be consistent with the limited literature in the AMI-CS literature. In a 2019 study using the HCUP-National Readmissions Database (HCUP-NRD) data from 2010– 2014, Sud et al. demonstrated that in older ST-segment elevation AMI-CS (STEMI-CS) patients (≥60 years), Medicaid and private insurance patients had a similar incidence of 30-day unplanned readmissions compared to the Medicare populations.19 In 2018, Mahmoud et al studied AMI-CS population using the 2013–2014 HCUP-NRD database and demonstrated that there was a statistically significant lower 30-day readmission in private insurance patients compared to those with Medicaid and Medicare.5 This study does not comment on the uninsured population or further subdivide the self-pay population to provide comparative insights with the current study. A 2019 study by Ando et al in a population of STEMI-CS patients demonstrated safety net hospitals, which have a higher percentage of Medicaid and self-pay patients compared to non-safety net hospitals, were also associated higher mortality, lower rates of PCI, and higher median costs.20 There was a decrease in the percentage of uninsured patients from 2014, likely due to the implementation of the Affordable Care Act, however further analyses of AMI-CS by insurance coverage, to look at the increase in Medicaid population is needed. Despite a consistent decrease in in-hospital mortality during this study period, the absolute unadjusted mortality for privately insured individuals in 2000 was lower than that achieved for uninsured individuals in 2016, suggestive of the persistent disparities in these two groups.
While there are limited data for the AMI-CS population, closer parallels can be drawn with insurance/income status with outcomes in the related cardiovascular disease literature. In a 2017 study by Pancholy et al, the authors use HCUP-NIS database spanning 2003–2014 to study the effect of insurance status on the adult STEMI population.4 In this study, the uninsured population was largely composed of individuals who had lower than the median income based on zip code. Uninsured patients were younger, male, with lower income and had similar lengths of stay and total charges, but slightly higher rates of CS, cardiac arrest, in-hospital mortality, and discharges against medical advice compared to patients with private insurance.4 Of note, this study included the five subcategories of insurance status, but did not directly compare uninsured with private insurance.4 Furthermore, the inclusion of Medicare and Medicaid populations might potentially cause an inclusion bias due to the different demographics of this population compared to uninsured and privately insured individuals.2
There are several potential explanations for the results seen in the current study. The uninsured population, though younger and with lower comorbidity, likely has significant contributors to in-hospital mortality such as higher rates of DNR status and palliative care referrals, higher rates of discharges against medical advice and differences in racial and geographic composition, all of which are known to influence clinical outcomes.38 It is possible these may reflect behaviors and decisions in the hospital that may have resulted in increased mortality. It has been previously shown that black patients have poorer medical outcomes in AMI, due to a combination of comorbidities resulting in earlier presentation of disease, poorer health care access that may result in worse initial presentation of disease, and lower average socioeconomic status.42 Furthermore, though not measurable in this study, implicit bias based on socio-economic demographics may continue to impact the care for these minority populations. As noted in our baseline demographics, higher rates of uninsured populations were noted in southern United States. Prior studies have demonstrated patients from the South have higher rates of chronic cardiovascular risk factors and disease, including obesity, diabetes, and low physical activity.43 This higher disease burden may contribute to the higher in-hospital mortality risk of the overall uninsured patients admitted for AMI-CS. Lastly, the lower cost and length of stay in the uninsured population may reflect the higher in-hospital mortality and faster discharges against medical advice or home. Therefore, insurance status appears to be closely related to social, economic, environmental, and racial factors and therefore, needs careful evaluation in future qualitative studies. Insurance status often serves as a surrogate for systematic socio-economic disparities, and therefore reflects the negatively reinforcing influences of age, race, sex, socio-economic status, and access to healthcare as demonstrated in literature.26, 38, 44–47 In addition to the above factors, provider perception of medical adherence may influence the final decision on whether PCI is offered to this population. Given the disastrous effects of stent thrombosis when dual antiplatelet therapy is not followed, providers may be apprehensive to offer PCI to a patient who may or may not be able to afford the needed medications.48–50
There are several strengths to the current study. Currently, there are limited data on the outcomes of uninsured AMI-CS patients because most databases are skewed towards patients with public or private insurance through claims-based data collection.2, 51 As such, there are studies of AMI-CS in Medicare and Medicaid populations, but not in uninsured populations.5, 19, 20 The HCUP-NIS is unique in that it is insurance-agnostic unlike other large databases that are claims-based. Moreover, this study offers a direct comparison between uninsured patients with private insurance patients to minimize the effect of age disparity. This is particularly important since age is a strong risk factor for worse outcomes in AMI-CS.6, 9, 26, 44, 46, 47, 52, 53 By reducing such confounders, directly comparing populations, using a database without enriching specific populations, and collecting a large nationwide population data, this study describes the disparities associated with lack of insurance for these critically ill patients.
Limitations
This study has several limitations, some of which are inherent to the analysis of a large administrative database. The HCUP-NIS attempts to mitigate potential errors by using internal and external quality control measures. The lack of angiographic data, such PCI location, lesion classification, presence of multi-vessel disease, and revascularization failure, that may significantly influence outcomes, were not available in this database. There are limited data on patient and family specific limitations to therapeutic options which may influence the clinical outcomes in this population. The ‘self-pay’ category may either include extremes of socio-economic status, however this study is unable to distinguish between these groups due to the inherent limitations of this administrative database. The uninsured cohort left the hospital against medical advice more often (1.7% vs. 0.3%) and we are unable to comment on the outcomes of this population. Since this was an inpatient database only, we are unable to comment on the continued management of these patients in the outpatient setting. This study does not study post-hospital long-term complications after PCI and AMI-CS, which may result in additional health care utilization that might be challenging for the uninsured population. Despite these limitations, this study addresses a significant knowledge gap highlighting the clinical outcomes of uninsured patients at a national level that is unique to this database.
CONCLUSIONS
Lack of insurance is associated with less frequent use of guideline-directed cardiac procedures in AMI-CS. Furthermore, uninsured individuals had higher rates of DNR status use, palliative care referrals, less frequent discharges to skilled nursing facilities, and higher in-hospital mortality. Further quantitative and qualitative research is needed into the underpinnings of decision-making in this population to help address these persistent healthcare disparities in AMI-CS outcomes.
Supplementary Material
Supplementary Table 1. Administrative codes used for identification of diagnoses and procedures
Supplementary Table 2. Predictors of mortality in AMI-CS
COMMENTARY.
What is new?
There are limited data on the outcomes uninsured patients presenting with AMI-CS compared to those private insured
Uninsured individuals received less frequent coronary angiography (79.5% vs. 81.0%), PCI (60.8% vs. 62.2%), and MCS (54% vs. 55.5%)
Uninsured individuals had higher palliative care referral (3.8% vs. 3.2%), DNR status use (4.4% vs. 3.2%) (all p<0.001), and higher in-hospital mortality (34.7% vs. 25.8%; adjusted OR 1.62 [95% CI 1.55–1.68; p<0.001).
What are the clinical implications?
Despite robust guidelines, uninsured individuals received less frequent guideline directed therapies and had worse in-hospital outcomes
Insurance status may be a marker of worse socio-economic profile that may indicate systematic bias towards minorities and disadvantaged sections of the society
Further research into health care inequalities in AMI-CS is warranted to improve clinical outcomes
SOURCES OF FUNDING
Dr. Saraschandra Vallabhajosyula is supported by the Clinical and Translational Science Award (CTSA) Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.
ABBREVIATIONS
- AMI
acute myocardial infarction
- CI
confidence interval
- CS
cardiogenic shock
- DNR
do-not-resuscitate
- HCUP
Healthcare Cost and Utilization Project
- ICD-9CM
International Classification of Diseases-9 Clinical Modification
- ICD-10CM
International Classification of Diseases-10 Clinical Modification
- MCS
mechanical circulatory support
- NIS
National/Nationwide Inpatient Sample
- NRD
National Readmissions Database
- OR
odds ratio
- PCI
percutaneous coronary intervention
- STEMI
ST-segment elevation myocardial infarction
Footnotes
DISCLOSURES
Dr. Jaffe has been a consultant for Beckman, Abbott, Siemens, Roche, ET Healthcare, Sphingotoec, Quidel, Brava, Blade, and Novartis. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
REFERENCES
- 1.Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R and Gomez SL. Trends in cancer survival by health insurance status in California from 1997 to 2014. JAMA Oncol. 2018;4:317–323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Patel N, Gupta A, Doshi R, Kalra R, Bajaj NS, Arora G and Arora P. In-hospital management and outcomes after ST-segment-elevation myocardial infarction in Medicaid beneficiaries compared with privately insured individuals. Circ Cardiovasc Qual Outcomes. 2019;12:e004971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Berchick ER, Barnett JC and Upton RD. Health insurance coverage in the United States: 2018. 2018;https://www.census.gov/content/dam/Census/library/publications/2019/demo/p60-267.pdf.
- 4.Pancholy S, Patel G, Pancholy M, Nanavaty S, Coppola J, Kwan T and Patel T. Association between health insurance status and in-hospital outcomes after ST-segment elevation myocardial infarction. Am J Cardiol. 2017;120:1049–1054. [DOI] [PubMed] [Google Scholar]
- 5.Mahmoud AN, Elgendy IY, Mojadidi MK, Wayangankar SA, Bavry AA, Anderson RD, Jneid H and Pepine CJ. Prevalence, causes, and predictors of 30-day readmissions following hospitalization with acute myocardial infarction complicated by cardiogenic shock: findings from the 2013–2014 National Readmissions Database. J Am Heart Assoc. 2018;7:e008235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Vallabhajosyula S, Kumar V, Sundaragiri PR, Cheungpasitporn W, Bell MR, Singh M, Jaffe AS and Barsness GW. Influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction in the United States. PLoS One. 2020;15:e0243810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Vallabhajosyula S, Desai VK, Sundaragiri PR, Cheungpasitporn W, Doshi R, Singh V, Jaffe AS, Lerman A and Barsness GW. Influence of primary payer status on non-ST-segment elevation myocardial infarction: 18-year retrospective cohort national temporal trends, management, and outcomes. Ann Transl Med. 2021;9:1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Vallabhajosyula S, Kumar V, Vallabhajosyula S, Subramaniam AV, Patlolla SH, Verghese D, Ya’Qoub L, Stulak JM, Sandhu GS, Prasad A, Holmes DR Jr. and Barsness GW. Acute myocardial infarction-cardiogenic shock in patients with prior coronary artery bypass grafting: A 16-year national cohort analysis of temporal trends, management, and outcomes. Int J Cardiol. 2020;310:9–15. [DOI] [PubMed] [Google Scholar]
- 9.Vallabhajosyula S, Dunlay SM, Prasad A, Kashani K, Sakhuja A, Gersh BJ, Jaffe AS, Holmes DR Jr. and Barsness GW. Acute Noncardiac organ failure in acute myocardial infarction with cardiogenic shock. J Am Coll Cardiol. 2019;73:1781–1791. [DOI] [PubMed] [Google Scholar]
- 10.Vallabhajosyula S, Kashani K, Dunlay SM, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Gersh BJ, Jaffe AS and Barsness GW. Acute respiratory failure and mechanical ventilation in cardiogenic shock complicating acute myocardial infarction in the USA, 2000–2014. Ann Intensive Care. 2019;9:96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Vallabhajosyula S, Patlolla SH, Verghese D, Ya’Qoub L, Kumar V, Subramaniam AV, Cheungpasitporn W, Sundaragiri PR, Noseworthy PA, Mulpuru SK, Bell MR, Gersh BJ and Deshmukh AJ. Burden of arrhythmias in acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol. 2020;125:1774–1781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Vallabhajosyula S, Dunlay SM, Prasad A, Sangaralingham LR, Kashani K, Shah ND and Jentzer JC. Cardiogenic shock and cardiac arrest complicating ST-segment elevation myocardial infarction in the United States, 2000–2017. Resuscitation. 2020;155:55–64. [DOI] [PubMed] [Google Scholar]
- 13.Vallabhajosyula S, Dunlay SM, Murphree DH Jr., Barsness GW, Sandhu GS, Lerman A and Prasad A. Cardiogenic shock in takotsubo cardiomyopathy versus acute myocardial infarction: An 8-year national perspective on clinical characteristics, management, and outcomes. JACC Heart Fail. 2019;7:469–476. [DOI] [PubMed] [Google Scholar]
- 14.Vallabhajosyula S, Subramaniam AV, Murphree DH Jr., Patlolla SH, Ya’Qoub L, Kumar V, Verghese D, Cheungpasitporn W, Jentzer JC, Sandhu GS, Gulati R, Shah ND, Gersh BJ, Holmes DR Jr., Bell MR and Barsness GW. Complications from percutaneous-left ventricular assist devices versus intra-aortic balloon pump in acute myocardial infarction-cardiogenic shock. PLoS One. 2020;15:e0238046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Subramaniam AV, Barsness GW, Vallabhajosyula S and Vallabhajosyula S. Complications of temporary percutaneous mechanical circulatory support for cardiogenic shock: an appraisal of contemporary literature. Cardiol Ther. 2019;8:211–228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Vallabhajosyula S, O’Horo JC, Antharam P, Ananthaneni S, Vallabhajosyula S, Stulak JM, Eleid MF, Dunlay SM, Gersh BJ, Rihal CS and Barsness GW. Concomitant intra-aortic balloon pump use in cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation. Circ Cardiovasc Interv. 2018;11:e006930. [DOI] [PubMed] [Google Scholar]
- 17.Vallabhajosyula S, Ya’Qoub L, Kumar V, Verghese D, Subramaniam AV, Patlolla SH, Desai VK, Sundaragiri PR, Cheungpasitporn W, Deshmukh AJ, Kashani K and Barsness GW. Contemporary national outcomes of acute myocardial infarction-cardiogenic shock in patients with prior chronic kidney disease and end-stage renal disease. J Clin Med. 2020;9:3702. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Vallabhajosyula S, Prasad A, Gulati R and Barsness GW. Contemporary prevalence, trends, and outcomes of coronary chronic total occlusions in acute myocardial infarction with cardiogenic shock. Int J Cardiol Heart Vasc. 2019;24:100414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Sud K, Haddadin F, Tsutsui RS, Parashar A, Bandyopadhyay D, Ellis SG, Tuzcu EM and Kapadia S. Readmissions in ST-elevation myocardial infarction and cardiogenic shock (from Nationwide Readmission Database). Am J Cardiol. 2019; 124:1841–1850. [DOI] [PubMed] [Google Scholar]
- 20.Ando T, Akintoye E, Adegbala O, Ashraf S, Shokr M, Takagi H, Grines CL, Afonso L and Briasoulis A. In-hospital outcomes of ST-segment elevation myocardial infarction complicated with cardiogenic shock at safety-net hospitals in the United States (from the Nationwide Inpatient Sample). Am J Cardiol. 2019;124:485–490. [DOI] [PubMed] [Google Scholar]
- 21.Introduction to the HCUP Nationwide Inpatient Sample 2009. http://wwwhcup-usahrqgov/db/nation/nis/NIS_2009_INTRODUCTIONpdf Acessed July 25, 2021.
- 22.Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE and Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–9. [DOI] [PubMed] [Google Scholar]
- 23.Anand V, Vallabhajosyula S, Cheungpasitporn W, Frantz RP, Cajigas HR, Strand JJ and DuBrock HM. Inpatient palliative care use in patients with pulmonary arterial hypertension: Temporal trends, predictors, and outcomes. Chest. 2020;158:2568–2578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Patlolla SH, Sundaragiri PR, Cheungpasitporn W, Doshi R, Barsness GW, Rabinstein AA, Jaffe AS and Vallabhajosyula S. Intracranial hemorrhage complicating acute myocardial infarction: an 18-year national study of temporal trends, predictors, and outcomes. J Clin Med. 2020;9:2717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Subramaniam AV, Patlolla SH, Cheungpasitporn W, Sundaragiri PR, Miller PE, Barsness GW, Bell MR, Holmes DR Jr. and Vallabhajosyula S. Racial and ethnic disparities in management and outcomes of cardiac arrest complicating acute myocardial infarction. J Am Heart Assoc. 2021;10:e019907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Vojjini R, Patlolla SH, Cheungpasitporn W, Kumar A, Sundaragiri PR, Doshi RP, Jaffe AS, Barsness GW, Holmes DR, Rab ST and Vallabhajosyula S. Racial disparities in the utilization and outcomes of temporary mechanical circulatory support for acute myocardial infarction-cardiogenic shock. J Clin Med. 2021;10:1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Vallabhajosyula S, Patlolla SH, Bell MR, Cheungpasitporn W, Stulak JM, Schears GJ, Barsness GW and Holmes DR. Same-day versus non-simultaneous extracorporeal membrane oxygenation support for in-hospital cardiac arrest complicating acute myocardial infarction. J Clin Med. 2020;9:2613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Vallabhajosyula S, Ya’Qoub L, Dunlay SM, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Jaffe AS, Gersh BJ and Kashani K. Sex disparities in acute kidney injury complicating acute myocardial infarction with cardiogenic shock. ESC Heart Fail. 2019;6:874–877. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Vallabhajosyula S, Dunlay SM, Barsness GW, Elliott Miller P, Cheungpasitporn W, Stulak JM, Rihal CS, Holmes DR Jr., Bell MR and Miller VM. Sex disparities in the use and outcomes of temporary mechanical circulatory support for acute myocardial infarction-cardiogenic shock. CJC Open. 2020;2:462–472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Vallabhajosyula S, Kanwar S, Aung H, Cheungpasitporn W, Raphael CE, Gulati R and Singh M. Temporal trends and outcomes of left ventricular aneurysm after acute myocardial infarction. Am J Cardiol. 2020;133:32–38. [DOI] [PubMed] [Google Scholar]
- 31.Patlolla SH, Kanwar A, Cheungpasitporn W, Doshi RP, Stulak JM, Holmes DR Jr., Bell MR, Singh M and Vallabhajosyula S. Temporal trends, clinical characteristics, and outcomes of emergent coronary artery bypass grafting for acute myocardial infarction in the United States. J Am Heart Assoc. 2021;10:e020517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Vallabhajosyula S, Patlolla SH, Murphree DH, Cheungpasitporn W, Holme DR Jr. and Gersh BJ. Temporal trends, management, and outcomes of acute myocardial infarction with concomitant respiratory infections. Am J Cardiol. 2021;150:1–7. [DOI] [PubMed] [Google Scholar]
- 33.Aggarwal G, Patlolla SH, Aggarwal S, Cheungpasitporn W, Doshi R, Sundaragiri PR, Rabinstein AA, Jaffe AS, Barsness GW, Cohen M and Vallabhajosyula S. Temporal trends, predictors, and outcomes of acute ischemic stroke in acute myocardial infarction in the United States. J Am Heart Assoc. 2021;10:e017693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Vallabhajosyula S, Arora S, Lahewala S, Kumar V, Shantha GPS, Jentzer JC, Stulak JM, Gersh BJ, Gulati R, Rihal CS, Prasad A and Deshmukh AJ. Temporary mechanical circulatory support for refractory cardiogenic shock before left ventricular assist device surgery. J Am Heart Assoc. 2018;7:e010193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Vallabhajosyula S, Prasad A, Sandhu GS, Bell MR, Gulati R, Eleid MF, Best PJM, Gersh BJ, Singh M, Lerman A, Holmes DR Jr., Rihal CS and Barsness GW. Ten-year trends, predictors, and outcomes of mechanical circulatory support in percutaneous coronary intervention for acute myocardial infarction with cardiogenic shock. EuroIntervention. 2021;16:e1254–e1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Vallabhajosyula S, Arora S, Sakhuja A, Lahewala S, Kumar V, Shantha GPS, Egbe AC, Stulak JM, Gersh BJ, Gulati R, Rihal CS, Prasad A and Deshmukh AJ. Trends, predictors, and outcomes of temporary mechanical circulatory support for postcardiac surgery cardiogenic shock. Am J Cardiol. 2019;123:489–497. [DOI] [PubMed] [Google Scholar]
- 37.Vallabhajosyula S, Payne SR, Jentzer JC, Sangaralingham LR, Kashani K, Shah ND, Prasad A and Dunlay SM. Use of post-acute care services and readmissions after acute myocardial infarction complicated by cardiac arrest and cardiogenic shock. Mayo Clin Proc Innov Qual Outcomes. 2021;5:320–329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Vallabhajosyula S, Prasad A, Dunlay SM, Murphree DH Jr., Ingram C, Mueller PS, Gersh BJ, Holmes DR Jr. and Barsness GW. Utilization of palliative care for cardiogenic shock complicating acute myocardial infarction: A 15-year national perspective on trends, disparities, predictors, and outcomes. J Am Heart Assoc. 2019;8:e011954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Vallabhajosyula S, Patlolla SH, Miller PE, Cheungpasitporn W, Jaffe AS, Gersh BJ, Holmes DR Jr., Bell MR and Barsness GW. Weekend effect in the management and outcomes of acute myocardial infarction in the United States, 2000–2016. Mayo Clin Proc Innov Qual Outcomes. 2020;4:362–372. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Khera R, Angraal S, Couch T, Welsh JW, Nallamothu BK, Girotra S, Chan PS and Krumholz HM. Adherence to Methodological Standards in Research Using the National Inpatient Sample. JAMA. 2017;318:2011–2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Khera R and Krumholz HM. With great power comes great responsibility: big data research from the National Inpatient Sample. Circ Cardiovasc Qual Outcomes. 2017;10:e003846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Arora S, Stouffer GA, Kucharska-Newton A, Vaduganathan M, Qamar A, Matsushita K, Kolte D, Reynolds HR, Bangalore S, Rosamond WD, Bhatt DL and Caughey MC. Fifteen-year trends in management and outcomes of non-ST-segment-elevation myocardial infarction among black and white patients: the ARIC community surveillance study, 2000–2014. J Am Heart Assoc. 2018;7:e010203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Geiss LS, Kirtland K, Lin J, Shrestha S, Thompson T, Albright A and Gregg EW. Changes in diagnosed diabetes, obesity, and physical inactivity prevalence in US counties, 2004–2012. PLoS One. 2017;12:e0173428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Vallabhajosyula S, Vallabhajosyula S, Dunlay SM, Hayes SN, Best PJM, Brenes-Salazar JA, Lerman A, Gersh BJ, Jaffe AS, Bell MR, Holmes DR Jr. and Barsness GW. Sex and gender disparities in the management and outcomes of acute myocardial infarction-cardiogenic shock in older adults. Mayo Clin Proc. 2020;95:1916–1927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Vallabhajosyula S, Verghese D, Desai VK, Sundaragiri PR and Miller VM. Sex differences in acute cardiovascular care: a review and needs assessment. Cardiovasc Res. 2021; doi: 10.1093/cvr/cvab063 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Vallabhajosyula S, Ya’Qoub L, Singh M, Bell MR, Gulati R, Cheungpasitporn W, Sundaragiri PR, Miller VM, Jaffe AS, Gersh BJ, Holmes DR Jr. and Barsness GW. Sex disparities in the management and outcomes of cardiogenic shock complicating acute myocardial infarction in the young. Circ Heart Fail. 2020;13:e007154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Chouairi F, Vallabhajosyula S, Mullan C, Mori M, Geirsson A, Desai NR, Ahmad T and Miller PE. Transition to advanced therapies in elderly patients supported by extracorporeal membrane oxygenation therapy. J Card Fail. 2020;26:1086–1089. [DOI] [PubMed] [Google Scholar]
- 48.Palacio AM, Uribe C, Hazel-Fernandez L, Li H, Tamariz LJ, Garay SD and Carrasquillo O. Can phone-based motivational interviewing improve medication adherence to antiplatelet medications after a coronary stent among racial minorities? A randomized trial. J Gen Intern Med. 2015;30:469–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Palacio AM, Vidot DC, Tamariz LJ, Uribe C, Hazel-Fernandez L, Li H, Garay SD and Carrasquillo O. Can we identify minority patients at risk of nonadherence to antiplatelet medication at the time of coronary stent placement? J Cardiovasc Nurs. 2017;32:522–529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Smolderen KG, Spertus JA, Tang F, Oetgen W, Borden WB, Ting HH and Chan PS. Treatment differences by health insurance among outpatients with coronary artery disease: insights from the national cardiovascular data registry. J Am Coll Cardiol. 2013;61:1069–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Gaglia MA Jr., Torguson R, Xue Z, Gonzalez MA, Ben-Dor I, Maluenda G, Mahmoudi M, Sardi G, Wakabayashi K, Kaneshige K, Suddath WO, Kent KM, Satler LF, Pichard AD and Waksman R. Effect of insurance type on adverse cardiac events after percutaneous coronary intervention. Am J Cardiol. 2011;107:675–80. [DOI] [PubMed] [Google Scholar]
- 52.Vallabhajosyula S, Dunlay SM, Bell MR, Miller PE, Cheungpasitporn W, Sundaragiri PR, Kashani K, Gersh BJ, Jaffe AS, Holmes DR and Barsness GW. Epidemiological trends in the timing of in-hospital death in acute myocardial infarction-cardiogenic shock in the United States. J Clin Med. 2020;9:2094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Vallabhajosyula S, Dunlay SM, Barsness GW, Rihal CS, Holmes DR Jr., and Prasad A. Hospital-level disparities in the outcomes of acute myocardial infarction with cardiogenic shock. Am J Cardiol. 2019;124:491–498. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplementary Table 1. Administrative codes used for identification of diagnoses and procedures
Supplementary Table 2. Predictors of mortality in AMI-CS
